Melo John

Avg. Two Year Performance

No purchase track record
70% Avg. Sale Return
30% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return6%6%31%55%70%
Sale Success Rate10 of 158 of 1512 of 1512 of 1513 of 15

Amyris, Inc.

Drugs » Biotechnology

President and CEO, Director:

Holdings: 509.86K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Kior Inc

Energy » Oil & Gas Refining & Marketing

:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--